These important findings reinforce the potential of MGAT4EP as a potential prognostic marker for breast cancer, assisting clinicians in identifying high-risk patients for metastasis and providing valuable insights for individualized treatment strategies. This evidence concerns the gene MGAT4EP and breast cancer.